# Ohio Breweries Challenge DeWine’s THC Drink Ban > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/ohio-cannabis-beverage-regulation-thc-drink-ban/ > **Published:** 2026-04-03T18:02:10-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:56:40-04:00 > **Clinical Summary:** Explore Ohio cannabis beverage regulation as breweries challenge the THC drink ban, impacting patient access and product safety in cannabis dosing. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic PolicyEdiblesDosingRegulationThc Why This Matters THC beverages represent a rapidly growing cannabis product category with distinct pharmacokinetics compared to traditional edibles or inhalation routes. Regulatory uncertainty around these products creates challenges for both [patient access](https://cedclinic.com/iowa-medical-cannabis-dispensaries-expansion/) to consistent dosing and clinician ability to provide evidence-based guidance on onset, duration, and safety profiles. Clinical Summary Ohio’s regulatory dispute over THC-infused beverages highlights the complex legal landscape surrounding cannabis products that don’t fit traditional categories. THC beverages typically have faster onset than solid edibles due to sublingual and gastric absorption, but slower than [inhalation methods](https://cedclinic.com/respiratory-effects-inhalational-marijuana/). The regulatory framework affects product standardization, dosing consistency, and quality control measures that impact patient safety and therapeutic predictability. Dr. Caplan’s Take “When states create regulatory uncertainty around specific cannabis product forms, patients lose access to potentially beneficial delivery methods while being pushed toward less regulated alternatives. This kind of policy volatility makes evidence-based clinical recommendations nearly impossible.” Clinical Perspective 🧠 Clinicians should be aware that patients may be accessing THC beverages through various legal and regulatory pathways with different safety standards. When discussing [cannabis therapeutics](https://cedclinic.com/firearms-regulatory-guidance-cannabis/), ask specifically about beverage products and counsel patients on the importance of consistent dosing and regulated sourcing regardless of product form. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Ohio%20breweries%20push%20to%20overturn%20DeWine%27s%20THC%20drink%20ban%20-%2013ABC%20%40drcaplan&url=https%3A//www.13abc.com/2026/04/03/ohio-breweries-push-overturn-dewines-thc-drink-ban/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.13abc.com/2026/04/03/ohio-breweries-push-overturn-dewines-thc-drink-ban/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Ohio%20breweries%20push%20to%20overturn%20DeWine%27s%20THC%20drink%20ban%20-%2013ABC%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.13abc.com/2026/04/03/ohio-breweries-push-overturn-dewines-thc-drink-ban/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.13abc.com/2026/04/03/ohio-breweries-push-overturn-dewines-thc-drink-ban/](https://www.13abc.com/2026/04/03/ohio-breweries-push-overturn-dewines-thc-drink-ban/) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating for this cannabis news?](#What_is_the_clinical_relevance_rating_for_this_cannabis_news) - [What type of cannabis products does this news relate to?](#What_type_of_cannabis_products_does_this_news_relate_to) - [What are the main topic areas covered in this article?](#What_are_the_main_topic_areas_covered_in_this_article) - [Why should healthcare providers pay attention to this information?](#Why_should_healthcare_providers_pay_attention_to_this_information) - [Is this information considered current and relevant?](#Is_this_information_considered_current_and_relevant) - [Related](#Related) ## FAQ #### What is the clinical relevance rating for this cannabis news? This article has been assigned CED Clinical Relevance #70, indicating “Notable Clinical Interest.” This rating suggests emerging findings or policy developments that are worth monitoring closely by healthcare professionals. #### What type of cannabis products does this news relate to? Based on the article tags, this news specifically relates to [cannabis edibles](https://cedclinic.com/decarboxylating-cannabis-process-why-how/). The content appears to focus on policy and regulatory aspects surrounding edible cannabis products. #### What are the main topic areas covered in this article? The article covers four key areas: policy developments, edibles regulations, dosing guidelines, and general regulatory framework. These topics suggest comprehensive coverage of the regulatory landscape for [cannabis edibles](https://cedclinic.com/decarboxylating-cannabis-process-why-how/). #### Why should healthcare providers pay attention to this information? The “Notable Clinical Interest” rating indicates this information contains emerging findings or policy developments relevant to clinical practice. Healthcare providers should monitor these developments as they may impact [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) and treatment protocols. #### Is this information considered current and relevant? Yes, the article is marked as “New” content from CED Clinic’s cannabis news section. The clinical relevance rating system suggests this represents timely information that healthcare professionals should be aware of in their practice. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [7 THC Drink Brands To Celebrate 4/20 – Forbes](https://cedclinic.com/cbd-gummies-guide-online-safe-guide-health-conscious-adults/) Discover popular THC drink brands making waves in the cannabis beverage market this 4/20. [Explore THC Drink Brands](https://cedclinic.com/cbd-gummies-guide-online-safe-guide-health-conscious-adults/) [Will hemp products be banned in 2026? Kentucky brand introduces new THC drinks](https://cedclinic.com/hemp-derived-intoxicating-products-ban-2026-kentucky-thc-drinks/) Learn about regulatory changes affecting hemp products and new THC drink introductions in Kentucky. [Read About Hemp Product Changes](https://cedclinic.com/hemp-derived-intoxicating-products-ban-2026-kentucky-thc-drinks/) [DC mayor proposes allowing cannabis drinks – NBC4 Washington](https://cedclinic.com/cannabis-beverages-pharmacokinetics-dosing-safety/) Stay informed on proposals to legalize cannabis drinks in Washington DC and their potential impact. [Learn About DC Cannabis Proposals](https://cedclinic.com/cannabis-beverages-pharmacokinetics-dosing-safety/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).